References
- Karamichalis JM, Putnam JB Jr, Lambright ES. Cardiovascular complications after lung surgery. Thorac Surg Clin 2006;16:253-60. https://doi.org/10.1016/j.thorsurg.2006.05.009
- Cohn SL. Preoperative cardiac evaluation of lung resection candidates. Throac Surg Clin 2008;18:45-59. https://doi.org/10.1016/j.thorsurg.2007.11.006
- Clerico A, Emdin M. Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review. Clin Chem 2004;50:33-50. https://doi.org/10.1373/clinchem.2003.024760
- Phua J, Lim TK, Lee KH. B-type natriuretic peptide: issues for intensivist and pulmonologist. Crit Care Med 2005;33:2094-103. https://doi.org/10.1097/01.CCM.0000178351.03327.9F
- Yeh HM, Lau HP, Lin JM, Sun WZ, Wang MJ, Lai LP. Preoperative plasma N-terminal pro-brain natriuretic peptide as a marker of cardiac risk in patients undergoing elective non-cardiac surgery. Br J Surg 2005;92:1041-5. https://doi.org/10.1002/bjs.4947
- Cuthbertson BH, Amiri AR, Croal BL, et al. Utility of B-type natriuretic peptide in predicting perioperative cardiac events in patients undergoing major non-cardiac surgery. Br J Anaesth 2007;99:170-6. https://doi.org/10.1093/bja/aem158
- Wazni OM, Martin DO, Marrouche NF, et al. Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery. Circulation 2004;110:124-7. https://doi.org/10.1161/01.CIR.0000134481.24511.BC
- Roselli EE, Murthy SC, Rice TW, et al. Atrial fibrillation complicating lung cancer resection. J Thorac Cardiovasc Surg 2005;130:438-44.
- Asamura H, Naruke T, Tsuchiya R, Goya T, Kondo H, Suemasu K. What are the risk factors for arrhythmias after thoracic operations? A retrospective multivariate analysis of 267 consecutive thoracic operations. J Thorac Cardiovasc Surg 1993;106:1104-10.
- Halm EA, Browner WS, Tubau JF, Tateo IM, Mangano DT. Echocardiography for assessing cardiac risk in patients having noncardiac surgery. Study of Perioperative Ischemia Research Group. Ann Intern Med 1996;125:433-41. https://doi.org/10.7326/0003-4819-125-6-199609150-00001
- Pedersen T, Kelbaek H, Munck O. Cardiopulmonary complications in high-risk surgical patients: the value of preoperative radionuclide cardiography. Acta Anaesthesiol Scand 1990;34:183-9. https://doi.org/10.1111/j.1399-6576.1990.tb03067.x
- Leppo J, Plaja J, Gionet M, Tumolo J, Paraskos JA, Cutler BS. Noninvasive evaluation of cardiac risk before elective vascular surgery. J Am Coll Cardiol 1987;9:269-76. https://doi.org/10.1016/S0735-1097(87)80374-1
- Kontos MC, Brath LK, Akosah KO, Mohanty PK. Cardiac complications in noncardiac surgery: relative value of resting two-dimensional echocardiography and dipyridamole thallium imaging. Am Heart J 1996;132:559-66. https://doi.org/10.1016/S0002-8703(96)90238-0
- Eagle KA, Brundage BH, Chaitman BR, et al. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 1996;27:910-48. https://doi.org/10.1016/0735-1097(95)99999-X
- Cardinale D, Colombo A, Sandri MT, et al. Increased perioperative N-terminal pro-B-type natriuretic peptide levels predict atrial fibrillation after thoracic surgery for lung cancer. Circulation 2007;115:1339-44. https://doi.org/10.1161/CIRCULATIONAHA.106.647008
- Hunt PJ, Richards AM, Nicholls MG, Yandle TG, Doughty RN, Espiner EA. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin Endocrinol 1997;47:287-96. https://doi.org/10.1046/j.1365-2265.1997.2361058.x
- Talwar S, Squire IB, Davies JE, Barnett DB, Ng LL. Plasma N-terminal pro-brain natriuretic peptide and the ECG in the assessment of left-ventricular systolic dysfunction in a high risk population. Eur Heart J 1999;20:1736-44. https://doi.org/10.1053/euhj.1999.1694
- Richards AM, Nicholls MG, Yandle TG, et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 1998;97:1921-9. https://doi.org/10.1161/01.CIR.97.19.1921
- Jernberg T, Stridsberg M, Venge P, Lindahl B. N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation. J Am Coll Cardiol 2002;40:437-45. https://doi.org/10.1016/S0735-1097(02)01986-1
Cited by
- Preoperative B-type natriuretic peptides in patients undergoing noncardiac surgery: a cumulative meta-analysis vol.21, pp.4, 2011, https://doi.org/10.1080/22201181.2015.1075938
- Risk factors predictive of atrial fibrillation after lung cancer surgery vol.46, pp.8, 2011, https://doi.org/10.1007/s00595-015-1258-4
- Prevention of Atrial Fibrillation in High-risk Patients Undergoing Lung Cancer Surgery: The PRESAGE Trial vol.264, pp.2, 2016, https://doi.org/10.1097/sla.0000000000001626
- N-Terminal Pro-B-Type Natriuretic Peptide - Prognstic Value for Death Within 24 Hours in Severe Polytrauma Patients with Chest Trauma vol.24, pp.3, 2011, https://doi.org/10.2478/arsm-2018-0022